← Open Payments lookup

MEKDES NIGUSE: Open Payments

NPI 1437800935 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$697 in 32 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $697

Food & beverage: $697
CompanyPaymentsAmount
ABBVIE INC.15$324
Otsuka America Pharmaceutical, Inc.4$88
Neurocrine BioSciences, Inc.4$85
Takeda Pharmaceuticals U.S.A., Inc.3$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$58
Lundbeck LLC2$47
Supernus Pharmaceuticals, Inc.1$18
Teva Pharmaceuticals USA, Inc.1$14

Products named: VRAYLAR, REXULTI, INGREZZA, TRINTELLIX, CAPLYTA, Qelbree, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.